X2=0.112 - 默认版块 - Discuz! Board - Powered by Discuz! cinoma /drug therapy;Combined modality therapy 非小细胞肺癌（non-samll cell lung carcinoma, NSCLC）约占肺癌总数的80%［1］，就诊时绝大多数患者已失去手术机会，可选择放射治疗或化疗，由于NSCLC对
基于210个网页-相关网页
late non-small cell lung carcinoma 晚期非小细胞肺癌
resistant non-small cell lung carcinoma 耐药非小细胞肺癌
Non-small cell Lung Carcinoma radiotherapy 非小细胞肺癌放射疗法
Objective To investigate the clinical significance of systematic mediastinal lymphadenectomy in surgical treatment of non-small cell lung carcinoma.
目的探讨系统性纵隔淋巴结清扫在非小细胞肺癌外科治疗上的临床意义。
To detect the distribution pattern of glycoconjugates on the surface of A549 and H460 cells in non-small cell lung carcinoma(NSCLC) by lectin microarray.
目的 应用凝集素芯片检测非小细胞肺癌细胞系A549和H460细胞膜表面糖链表达类型。
Angiogenesis is a potential prognostic factor that has been investigated in patients with non-small-cell lung carcinoma.
在已调查过的非小细胞肺癌患者中，血管生成是一个潜在预后因子。
应用推荐